SCAS-BTT Bioanalysis Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

SCAS-BTT Bioanalysis General Information

Description

provider of the high-quality pharmacokinetics (PK) analysis service for clinical studies in Korea. The company conducts research and monitoring of lifestyle-related diseases through clinical trials based on medical information and biostatistics, thereby helping the company in total comprehensive research in specialized drugs and pharmaceutical development.

Contact Information

Website
www.scasbtt.en.ec21.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Ochang Scientific industrial Complex
  • 686-2, Yangcheong-ri
  • Cheongwon-gun, Chungcheongbuk-do
  • South Korea
+82
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Ochang Scientific industrial Complex
  • 686-2, Yangcheong-ri
  • Cheongwon-gun, Chungcheongbuk-do
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SCAS-BTT Bioanalysis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SCAS-BTT Bioanalysis‘s full profile, request access.

Request a free trial

SCAS-BTT Bioanalysis Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SCAS-BTT Bioanalysis‘s full profile, request access.

Request a free trial

SCAS-BTT Bioanalysis FAQs

  • When was SCAS-BTT Bioanalysis founded?

    SCAS-BTT Bioanalysis was founded in 2011.

  • Where is SCAS-BTT Bioanalysis headquartered?

    SCAS-BTT Bioanalysis is headquartered in Cheongwon-gun, South Korea.

  • What industry is SCAS-BTT Bioanalysis in?

    SCAS-BTT Bioanalysis’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is SCAS-BTT Bioanalysis a private or public company?

    SCAS-BTT Bioanalysis is a Private company.

  • What is SCAS-BTT Bioanalysis’s current revenue?

    The current revenue for SCAS-BTT Bioanalysis is .

  • Who are SCAS-BTT Bioanalysis’s investors?

    Biotoxtech and Sumika Chemical Analysis Service have invested in SCAS-BTT Bioanalysis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process